Journal
PATHOGENS
Volume 11, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/pathogens11040448
Keywords
oral microbiota; children; cancer; chemotherapy; oral mucositis
Categories
Funding
- Sara un angelo con la bandana ONLUS
Ask authors/readers for more resources
The oral cavity is the second largest microbiota in the human body, and it plays an important role in the pathogenesis of oral mucositis in children with cancer undergoing chemotherapy. Dysbiosis of the oral microbiota exacerbates inflammation and tissue damage.
The human oral cavity harbors the second most abundant microbiota after the gastrointestinal tract, with over 700 species currently identified in the oral microflora. The oral microbiota develops from intrauterine life and after birth is continuously shaped by several influencing factors. The perturbation of the diversity and proportions of species within the oral microbiota leads to dysbiosis and associated increased risk of local and systemic diseases. In children who receive chemotherapy for cancer, oral mucositis is a common and painful side effect that decreases quality of life (QoL) and treatment adherence. The oral microbiota undergoes a substantial dysbiosis as an effect of cancer and its treatment, characterized by lower richness and less diversity. Furthermore, this dysbiosis seems to promote pro-inflammatory cytokine release and pro-apoptotic mediators, enhancing the oral tissue damage. Further studies on the role of the oral microbiota in the pathogenesis of oral mucositis should be performed among children with cancer who receive chemotherapy, to find preventive and protective factors against the pathogenesis of oral mucositis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available